Akebia Therapeutics, Inc. , a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases.
Akebia Therapeutics stock last closed at $1.33, up 0.76% from the previous day, and has increased 19.82% in one year. It has overperformed other stocks in the Biotechnology industry by 0.3 percentage points. Akebia Therapeutics stock is currently +70.51% from its 52-week low of $0.78, and -46.37% from its 52-week high of $2.48.
As of Oct 4, 2024, there are 210.29M shares of AKBA outstanding. The market capitalization of AKBA is $279.68M. In the last 24 hours, 795,526 AKBA shares were traded.
How to Buy Akebia Therapeutics Stock
Not sure how to invest in Akebia Therapeutics stock? Here's how.
Decide where to buy Akebia Therapeutics stock: You need to decide on a stock brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you figure out where to buy Akebia Therapeutics stock.
Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
Deposit funds into your investment account: Select your method of payment and add your details.
Evaluate Akebia Therapeutics stock: The Akebia Therapeutics ticker symbol is AKBA. Is Akebia Therapeutics stock a good investment? Should you buy shares of AKBA? How do AKBA's underlying business fundamentals look? Do top analysts think Akebia Therapeutics is a good buy? Why has AKBA's stock price moved recently? (Hint: Our stock market research website can help you evaluate if AKBA is a good stock to buy).
Make your AKBA buy order: Decide if you will purchase AKBA shares at the current market price or use a limit order to purchase AKBA shares at a particular price.
Keep tabs on your AKBA position: Create a watchlist to keep tabs on your investment in Akebia Therapeutics shares.
Step 1: Decide where to buy Akebia Therapeutics stock
You will need an online brokerage account in order to access the NASDAQ market and buy AKBA stock.
A brokerage account is an investment account that enables you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
In our opinion, eToro is the best brokerage. Here's why:
You can invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
Access to global markets: From Technology to Energy, New York to Tokyo — you can fill your portfolio with stocks from the world's top exchanges.
Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by creating an account with eToro today.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've picked the best brokerage, the next step is to fill out some personal details so you are able to buy AKBA stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Akebia Therapeutics stock
Once you have chosen the best place to buy Akebia Therapeutics stock, it's critical to research their stock before you buy, so you truly comprehend the risk and opportunity.
Overview of key AKBA info
AKBA Price
$1.33
1w %
0%
1y %
19.82%
5y %
-65.9%
P/E
-6.33x
P/B
-8.29x
P/S
1.6x
PEG
N/A
Revenue
$174.50M
Earnings
-$40.44M
Fore. Rev. Growth
8.98%
Fore. Earn. Growth
N/A
Market Cap
$279.68M
Next Earnings
Nov 6, 2024
Next Dividend
N/A
AKBA Zen Score
WallStreetZen was built to help everyday investors perform more in-depth fundamental analysis.
Last year, AKBA revenue was $174.50M. Over the last 5 year, AKBA's revenue has grown by -9.44% per year. This was slower than the Biotechnology industry average of 61.66%.
No, Akebia Therapeutics doesn't provide an income stream by paying out dividends.
Get opinions from other investors
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Make your AKBA buy order
You have two main options:
Market order: A market order is an order to buy or sell a stock at the best available price. Market orders are generally fine for most investors.
Limit order: A limit order allows you to buy or sell a security at a specific price (or better). If you want to be certain you're buying or selling at an exact price, place a limit order.
Click the Open Trade button and eToro will execute the order.
If you need more assistance buying stocks on eToro, watch the helpful video below:
How much does it cost to buy one Akebia Therapeutics share?
As of Oct 4, 2024, it costs $1.33 to buy one share of Akebia Therapeutics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.67, you can buy 0.5 shares of AKBA.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.